COVID-19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence

J Clin Lab Anal. 2021 Jul;35(7):e23798. doi: 10.1002/jcla.23798. Epub 2021 Jun 1.

Abstract

Background: Homocysteine assessment has been proposed as a potential predictive biomarker for the severity of COVID-19 infection. The purpose of this review was to analyze the correlation between the prevalence of MTHFR C677 T gene polymorphism and COVID-19 incidence and mortality worldwide.

Methods: Data regarding MTHFR C677 T gene mutation were obtained from the interrogation of the Genome Aggregation Database (genomAD), which is publicly available from the web"https://gnomad.broadinstitute.org." COVID-19 cases, including prevalence and mortality, were obtained from"https://www.worldometers.info/coronavirus" 27 August 2020.

Results: There is a clear trend toward the worldwide prevalence of MTHFR 677 T and COVID-19 incidence and mortality. The prevalence of MTHFR 677 T allele in the Latino population, and the incidence and mortality for COVID-19 was higher for this ethnic group than that reported for most other populations globally. Statistical analysis showed a relatively strong correlation between C677 T and death from coronavirus.

Conclusions: Genetic polymorphism of MTHFR C677 T may modulate the incidence and severity of COVID-19 pandemic infection.

Keywords: C677 T mutation prevalence; COVID-19 vulnerability; Homocysteine; MTHFR gene.

MeSH terms

  • Alleles*
  • COVID-19 / enzymology*
  • COVID-19 / epidemiology*
  • COVID-19 / genetics
  • COVID-19 / mortality
  • Ethnicity / genetics
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Prevalence

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)